Fig. 3.
Fig. 3. Correlation analysis (Spearman test) of prothrombin fragment F1+2 versus Isoprostane-F2-III (•) and versus Isoprostane-F2-VI (▴) in healthy subjects (HS), in patients positive for antiphospholipid antibodies (aPL+), and in patients with systemic lupus erythematosus negative for antiphospholipid antibodies (SLE aPL−).

Correlation analysis (Spearman test) of prothrombin fragment F1+2 versus Isoprostane-F2-III (•) and versus Isoprostane-F2-VI (▴) in healthy subjects (HS), in patients positive for antiphospholipid antibodies (aPL+), and in patients with systemic lupus erythematosus negative for antiphospholipid antibodies (SLE aPL−).

Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal